Literature DB >> 12880687

Treatment with Propionibacterium acnes modulates the late phase reaction of immediate hypersensitivity in mice.

Eleni Gonçalves Braga1, Renata Zeigler Ananias, Juliana Sekeres Mussalem, Carla Cristina Squaiella, Ana Leda Figueiredo Longhini, Mario Mariano, Luiz R Travassos, Ieda Maria Longo-Maugéri.   

Abstract

The administration of killed Propionibacterium acnes suspension to mice enhances macrophage phagocytic and tumoricidal activities, have an adjuvant effect to antibody response and increases resistance to infection. Recent reports demonstrated that P. acnes treatment promotes IL-12 and IL-18 synthesis in mice inducing IFN-gamma release, enhancement of IgG2a switch and inhibition of Th2 cell expansion. These findings led us to investigate whether P. acnes could modulate hypersensitivity type I reaction observed in a murine model. Animals were implanted with heat coagulated hen's egg white (HEW) into the subcutaneous tissue, followed by OVA-challenge in the footpad. The observed reaction was characterized by elevated Th2 cytokine levels, especially IL-4 and increase in eosinophil infiltration as occurs in the late phase reaction (LPR) of type I hypersensitivity, a pattern observed in allergic asthma in human. Two different biological effects were induced by killed P. acnes depending on the experimental protocol used. When mice were treated with one dose of P. acnes per week during 3 weeks and the last dose administrated at the same time of HEW implantation, a strong adjuvant effect on type I hypersensitivity reaction with intense eosinophilic infiltration was observed. On the other hand, when the HEW implant was made 1 week after the administration of the last dose of P. acnes, animals developed a typical delayed type hypersensitivity reaction, and a cytokines pattern characteristic of the Th1 immune response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880687     DOI: 10.1016/s0165-2478(03)00079-8

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  10 in total

1.  Adjuvant effect of killed Propionibacterium acnes on mouse peritoneal B-1 lymphocytes and their early phagocyte differentiation.

Authors:  Juliana Sekeres Mussalem; Carla Cristina Squaiella-Baptistão; Daniela Teixeira; Tatiana Mina Yendo; Felipe Garutti Thies; Ana Flavia Popi; Mario Mariano; Ieda Longo-Maugéri
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

2.  Modulation of Th1/Th2 immune responses by killed Propionibacterium acnes and its soluble polysaccharide fraction in a type I hypersensitivity murine model: induction of different activation status of antigen-presenting cells.

Authors:  Carla Cristina Squaiella-Baptistão; Daniela Teixeira; Juliana Sekeres Mussalem; Mayari Eika Ishimura; Ieda Maria Longo-Maugéri
Journal:  J Immunol Res       Date:  2015-04-20       Impact factor: 4.818

3.  Treatment of Leishmania (Leishmania) Amazonensis-Infected Mice with a Combination of a Palladacycle Complex and Heat-Killed Propionibacterium acnes Triggers Protective Cellular Immune Responses.

Authors:  Carolina S Paladi; Danielle A M da Silva; Priscila D Motta; Daniel M Garcia; Daniela Teixeira; Ieda M Longo-Maugéri; Simone Katz; Clara L Barbiéri
Journal:  Front Microbiol       Date:  2017-03-06       Impact factor: 5.640

4.  Propionibacterium acnes Enhances the Immunogenicity of HIVBr18 Human Immunodeficiency Virus-1 Vaccine.

Authors:  Daniela Teixeira; Mayari Eika Ishimura; Juliana de Souza Apostólico; Jacqueline Miyuki Viel; Victor Cabelho Passarelli; Edecio Cunha-Neto; Daniela Santoro Rosa; Ieda Maria Longo-Maugéri
Journal:  Front Immunol       Date:  2018-02-07       Impact factor: 7.561

Review 5.  An Overview of B-1 Cells as Antigen-Presenting Cells.

Authors:  Ana F Popi; Ieda M Longo-Maugéri; Mario Mariano
Journal:  Front Immunol       Date:  2016-04-11       Impact factor: 7.561

6.  Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes.

Authors:  Dingyuan Jiang; Xiaoxi Huang; Jing Geng; Run Dong; Shuhong Li; Zheng Liu; Chen Wang; Huaping Dai
Journal:  Oncotarget       Date:  2016-06-07

7.  Killed Propionibacterium acnes enhances immunogenicity and tumor growth control of a dendritic-tumor cell hybrid vaccine in a murine melanoma model.

Authors:  Mayari E Ishimura; Daniela Teixeira; Gabriela da P Silveira; Mônica Gambero; Gabriel A C Gama; Bruna S O Pimenta; Elaine G Rodrigues; Ieda M Longo-Maugéri
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

8.  Improvement of Mesenchymal Stem Cell Immunomodulatory Properties by Heat-Killed Propionibacterium acnes via TLR2.

Authors:  Gabriela da Paz Silveira; Mayari Eika Ishimura; Daniela Teixeira; Layla Tesla Galindo; Agnes Araujo Sardinha; Marimelia Porcionatto; Ieda Maria Longo-Maugéri
Journal:  Front Mol Neurosci       Date:  2019-01-10       Impact factor: 5.639

9.  Protective Cellular Immune Response Induction for Cutaneous Leishmaniasis by a New Immunochemotherapy Schedule.

Authors:  Danielle A M da Silva; Fabiana R Santana; Simone Katz; Daniel M Garcia; Daniela Teixeira; Ieda M Longo-Maugéri; Clara L Barbiéri
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561

10.  Propionibacterium acnes-killed attenuates the inflammatory response and protects mice from sepsis by modulating inflammatory factors.

Authors:  José Bruno Nunes Ferreira da Silva; Samara Kelly Mendonça de Oliveira; Ingrid Araújo Campos; Carlson Helder Reis de Carvalho-Júnior; Thiago da Cunha Coutinho; Teresinha Gonçalves Silva
Journal:  Braz J Infect Dis       Date:  2013-01-03       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.